Skip to content

Clinical trials

Phase 1 Urinary Bladder Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1 Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20181
20191
20211
20224
20233
20245
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Unknown status7
Active, not recruiting3
Completed2
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2
BeiGene1
Beijing Biotech1
Chengdu CoenBiotech Co., Ltd1
Fudan University1
Pfizer1
Shanghai Fengxian District Central Hospital1
Shanghai PerHum Therapeutics Co., Ltd.1
Shanghai Pudong Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms22
Ovarian Neoplasms7
Esophageal Neoplasms6
Breast Neoplasms5
Pancreatic Neoplasms4
Prostatic Neoplasms4
Stomach Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Neoplasm Metastasis3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.